Mindfulness
July 27, 2026
Anat Atiya Malki, Ricardo Tarrasch
Abstract Objectives This study examined the impact of a mindfulness-based intervention on preschoolers chronically exposed to cross-border missile attacks and violence. Prolonged exposure to such hostilities has been linked to elevated levels of anxiety and behavioral difficulties in a substantial proportion of affected children. The primary objective was to reduce posttraumatic stress disorder...
Asian American Journal of Psychology
July 27, 2026
Shengli Dong, Chieh Li, Huijun Li et al.
Chinese American adolescents experience significant mental health challenges, including high rates of race and ethnicity-related stress, anxiety, depression, and suicide.Given the potential of mindfulness meditation to improve adolescent mental health, this preliminary study examines the cultural sensitivity of four brief mindfulness meditation videos through the ecological cultural validity...
July 27, 2026
Asher Wenig, David B Newman
preprint
This project will use a PRISMA-guided systematic review and meta-analysis to examine whether age moderates anxiety and depression outcomes following psychoactive-assisted treatments. In this review, psychoactive-assisted treatments are defined as clinically structured treatments involving classic serotonergic psychedelics, MDMA, ketamine, or esketamine. The term is intentionally broader than...
Progress in Neuro-Psychopharmacology and Biological Psychiatry
July 24, 2026
Omer Baruch, Nadav Reiss, Doron Todder et al.
Post-traumatic stress disorder (PTSD) remains difficult to prevent after trauma, highlighting the need for early interventions that reduce the risk of chronic symptom development. This controlled study investigated the preventive potential of 3,4-methylenedioxymethamphetamine (MDMA) in a validated rat model of PTSD induced by predator scent stress (PSS). Adult male Sprague-Dawley rats (N = 175)...
July 23, 2026
T Field
The prevalence of nightmares appears to be highly variable in this current literature on nightmares, ranging from low in healthy populations (6% to 11%), to slightly higher in those with medical problems (12% to 13%), significantly higher in individuals with neurological conditions (24% to 30%) and again significantly higher in those with psychiatric diagnoses (27% to 62%). Medical...
bioRxiv
July 23, 2026
William J. Tyler, E. Sellers, Michael B. McDonnell
preprint
Repeated low-dose psilocybin is being developed as a scalable outpatient treatment for mood and anxiety disorders, but chronic exposure raises concern because psilocin binds the cardiac serotonin 5-HT2B receptor, whose sustained agonism causes drug-induced valvular heart disease (VHD). We evaluated this risk using an exposure–response model that incorporates functional efficacy and exposure...
Revista Brasileira de Cannabis
July 22, 2026
Cláudio Yuri Rodrigues da Silva, Evelyn Abreu De Amorim, Lucas Gonçalves Vilas et al.
A Ecopsicologia é uma abordagem integradora que busca conectar a sustentabilidade à saúde mental e emocional com a reconexão do ser humano à natureza. Ela parte da premissa de que o bem-estar humano está intrinsecamente ligado ao equilíbrio ambiental, estimulando práticas que promovam a sustentabilidade e o contato direto com a natureza. Plantar sua própria cannabis para fins terapêuticos se...
JOURNAL OF Pharmacy and Tropical Issues
July 21, 2026
Evi Karota Bukit, Yuliani Krisna Lubis, Renya Loysa Sinurat et al.
Background: Breast cancer is a global health issue that not only affects physical health but also causes psychological distress and a decline in quality of life. Various non-pharmacological interventions have been developed to help patients adapt to the disease, one of which is mindfulness. Evidence regarding the effectiveness of mindfulness in breast cancer patients remains inconsistent,...
Frontiers in Psychiatry
July 21, 2026
David Martinez Garza, Ilya O. Blokhin, Jonathan Brett et al.
Since the introduction of disulfiram in 1951 (the first ever Food and Drug Administration (FDA)-approved medication for substance use disorders (SUDs)) (1), only seven other individual medications have been approved for the treatment of SUDs. While the repurpose of medications and different formulations increase the total number of FDA-approved medicines (Table 1 and(2)), the arsenal of...
Zenodo (CERN European Organization for Nuclear Research)
July 21, 2026
Michael Alvear
preprint
Music is often treated as an atmospheric accessory in psychedelic and ketamine therapy: useful, pleasant, optional, or merely calming. Across a curated evidence base of 41 studies, reviews, mechanistic papers, clinical reports, playlist-design papers, ketamine-specific studies, ceremonial-music papers, and counterarguments, music repeatedly appears as an active session-shaping variable. The...